[1]吕艳,张帆.糖尿病神经原膀胱的治疗现状[J].国际内分泌代谢杂志,2017,37(05):329-332.
　Lyu Yan*,Zhang Fan..Treatment of diabetic neurogenic bladder[J].International Journal of Endocrinology and Metabolism,2017,37(05):329-332.
点击复制

糖尿病神经原膀胱的治疗现状()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
37
期数:
2017年05期
页码:
329-332
栏目:
综述
出版日期:
2017-09-20

文章信息/Info

Title:
Treatment of diabetic neurogenic bladder
作者:
吕艳; 张帆
230032 合肥,安徽医科大学(吕艳); 518036 深圳,北京大学深圳医院内分泌科(吕艳,张帆)
Author(s):
Lyu Yan*;  Zhang Fan.
*Anhui Medical University, Hefei 230032, China
关键词:
糖尿病;  神经原膀胱;  化学药物治疗;  物理治疗
Keywords:
Diabetes mellitus;  Neuropathic bladder;  Chemotherapy;  Physiotherapy
文献标志码:
A
摘要:
糖尿病神经原膀胱(DNB)是糖尿病在泌尿系统最主要的并发症,其发病机制复杂,目前尚无特效的治疗方法。营养神经、调节神经递质、抗氧化应激、电刺激、导尿术等单一化学药物或物理治疗常难以达到临床治疗要求,理化联合治疗可协同增加疗效。近年来,干细胞和基因研究的兴起为DNB的治疗提供了新思路,但仍处于实验探索阶段
Abstract:
Diabetic neurogenic bladder(DNB)is the major complication in urinary system of diabetes mellitus. Its pathogenesis is complicated. For now, there is no special treatment for DNB. The single chemotherapy or physiotherapy, such as neurotrophic therapy, adjusting rotransmitters, anti-oxidative stress, electric stimulation, catheterization all has unsatisfactory effects. The combination of physical and chemical therapy will achieve better curative effects. In recent years, the research of stem cells and gene provides new idea for treatment of DNB, but it is still at the experimental stage.

参考文献/References:

[1] Gomez CS, Kanagarajah P, Gousse AE. Bladder dysfunction in patients with diabetes[J].Curr Urol Rep,2011,12(6):419-426. DOI:10.1007/s11934-011-0214-0.
[2] Devi P, Madhu K, Ganapathy B,et al. Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy[J].Indian J Pharmacol,2012,44(1):51-56. DOI:10.4103/0253-7613.91867.
[3] 尹洪君,王菲. 弥可保配合生物反馈疗法治疗糖尿病神经原性膀胱逼尿肌无力的临床研究[J]. 中国医学创新,2012,9(3):15-17.DOI:10.3969/j.issn.1674-4985.2012.03.007.
[4] Hohsfield LA, Geley S, Reindl M,et al. The generation of NGF-secreting primary rat monocytes: a comparison of different transfer methods[J].J Immunol Methods,2013,391(1-2):112-124. DOI:10.1016/j.jim.2013.02.016.
[5] Marchetti V, Menghini R, Rizza S,et al.Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling[J].Diabetes,2006,55(8):2231-2237. DOI:10.2337/db06-0369.
[6] Nagase K, Ito H, Aoki Y,et al. Co-administration of an α(1)-blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity[J].Int J Urol,2011,18(12):836-843. DOI:10.1111/j.1442-2042.2011.02868.x.
[7] 孟兆祥,王彤,尹正录,等. 电针结合经会阴BTX-A注射治疗脊髓操作后神经源性膀胱的临床研究[J].中国针炙,2015,35(1):17-20.DOI:10.13703/j.0255-2930.2015.01.005.
[8] Ramage AG. The role of central 5-hydroxytryptamine(5-HT, serotonin)receptors in the control of micturition[J].Br J Pharmacol,2006,147(Suppl 2):S120-S131. DOI:10.1038/sj.bjp.0706504.
[9] 赵富利,亓民,刘辉. 胰激肽原酶联合莫沙必利治疗糖尿病神经源性膀胱48例临床疗效分析[J]. 中国实用医药,2013,8(25):145-146. DOI:10.3969/j.issn.1673-7555.2013.25.109.
[10] 涂红坚. 5-羟色胺2A/2C受体激动剂DOI改善糖尿病大鼠排尿障碍的实验研究[D]. 苏州大学,2014.
[11] Palazuelos J, Ortega Z, Díaz-Alonso J,et al. CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling[J].J Biol Chem,2012,287(2):1198-1209. DOI:10.1074/jbc.M111.291294.
[12] Eftekhar T, Teimoory N, Miri E,et al. Posterior tibial nerve stimulation for treating neurologic bladder in women: a randomized clinical trial[J].Acta Med Iran,2014,52(11):816-821.
[13] Hotta N, Kawamori R, Fukuda M,et al. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy[J].Diabet Med,2012,29(12):1529-1533. DOI:10.1111/j.1464-5491.2012.03684.x.
[14] Kanika ND, Chang J, Tong Y,et al. Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways[J].BJU Int,2011,107(10):1676-1684. DOI:10.1111/j.1464-410X.2010.09655.x.
[15] Ha US, Bae WJ, Kim SJ,et al. Protective effect of cyanidin-3-O-β-D-glucopyranoside fraction from mulberry fruit pigment against oxidative damage in streptozotocin-induced diabetic rat bladder[J].Neurourol Urodyn,2013,32(5):493-499. DOI:10.1002/nau.22334.
[16] Benrath J, Brechtel C, Stark J,et al. Low dose of S+-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo[J].Br J Anaesth,2005,95(4):518-523. DOI:10.1093/bja/aei215.
[17] Bhutada P, Mundhada Y, Bansod K,et al. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes[J].Behav Brain Res,2011,220(1):30-41. DOI:10.1016/j.bbr.2011.01.022.
[18] Chen S, Zhu Y, Liu Z,et al. Grape seed proanthocyanidin extract ameliorates diabetic bladder dysfunction via the activation of the Nrf2 pathway[J].PLoS One,2015,10(5):e0126457. DOI:10.1371/journal.pone.0126457.
[19] 王峰,李帆,王继锋,等. α-硫辛酸联合甲钴胺对糖尿病神经源性膀胱尿流动力学及血清超氧化物歧化酶的影响[J]. 疑难病杂志,2016,15(5):456-459.DOI:10.3969/j.issn.1671-6450.2016.05.005.
[20] 王丽娜,周慧敏,郭玉卿,等. α-硫辛酸联合依帕司他和甲钴胺治疗糖尿病神经源性膀胱的临床研究[J]. 国际内分泌代谢杂志,2014,34(4):241-244. DOI:10.3760/cma.j.issn.1673-4157.2014.04.007.
[21] 李振兴,谭万寿,周斌,等. 神经节苷脂联合α-硫辛酸治疗糖尿病神经源性膀胱临床观察[J]. 现代生物医学进展,2011,11(16):3149-3151.
[22] 关红. 经皮低频脉冲电刺激对糖尿病膀胱患者的作用分析[J]. 中国实用医药,2014,(35):60-61.
[23] Chen G, Liao L, Miao D. Electrical stimulation of somatic afferent nerves in the foot increases bladder capacity in neurogenic bladder patients after sigmoid cystoplasty[J].BMC Urol,2015,15:26. DOI:10.1186/s12894-015-0023-8.
[24] 黄庆娟,劳丹华,韩满玲,等. 超短波在糖尿病神经源性膀胱治疗中的护理[J]. 护士进修杂志,2012,27(13):1205-1206. DOI:10.3969/j.issn.1002-6975.2012.13.025.
[25] 白博丽, 高兰平. 高压氧治疗糖尿病神经源膀胱的疗效观察[J]. 山西医药杂志(下半月刊), 2013,42(6):315-316. DOI:10.3969/j.issn.0253-9926.2013.06.047.
[26] 蔡月虹,吴秋英,陈春燕. 牵引导尿术在糖尿病神经源性膀胱尿潴留中的应用[J]. 实用糖尿病杂志,2012,8(3):62.
[27] 曾永保,梅志刚,董铮,等. 针灸治疗糖尿病膀胱临床研究的Meta分析[J]. 时珍国医国药,2012,23(1):198-201. DOI:10.3969/j.issn.1008-0805.2012.01.089.
[28] 祝丹,李凡. 物理治疗糖尿病神经源性膀胱患者的效果观察[J]. 中国实用神经疾病杂志,2015(11):128-129. DOI:10.3969/j.issn.1673-5110.2015.11.091.
[29] 白博丽,高兰平. 高压氧联合硫辛酸治疗糖尿病神经源膀胱的疗效观察[J]. 中国美容医学,2012,21(16):127. DOI:10.3969/j.issn.1008-6455.2012.16.108.
[30] Vaegler M, Lenis AT, Daum L,et al. Stem cell therapy for voiding and erectile dysfunction[J].Nat Rev Urol,2012,9(8):435-447. DOI:10.1038/nrurol.2012.111.
[31] Reid AJ, Sun M, Wiberg M,et al. Nerve repair with adipose-derived stem cells protects dorsal root ganglia neuronsfrom apoptosis[J].Neuroscience,2011,199:515-522. DOI:10.1016/j.neuroscience.2011.09.064.
[32] 陈潮江,周兴,郑煜,等. 神经干细胞移植治疗糖尿病大鼠神经源性膀胱的实验研究[J]. 国际泌尿系统杂志,2013,33(2):145-148. DOI:10.3760/cma.j.issn.1673-4416.2013.02.001.
[33] Shoae-Hassani A, Sharif S, Seifalian AM,et al. Endometrial stem cell differentiation into smooth muscle cell: a novel approach for bladder tissue engineering in women[J].BJU Int,2013,112(6):854-863. DOI:10.1111/bju.12195.

相似文献/References:

[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
　Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(05):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
　Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(05):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]

备注/Memo

备注/Memo:
通信作者:张帆,Email:szneifenmi@sina.com
更新日期/Last Update: 2017-09-30